Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy [Phase 1]
A completed Phase 1 trial evaluating neo-adjuvant combination immunotherapy in urothelial carcinoma of the bladder.
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Named Patient Program for Mitomycin for Pyelocalyceal Solution
This clinical-trials.gov update describes a named patient program for mitomycin-C delivered as a pyelocalyceal solution to treat urothelial …
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma. [Phase 3]
A Phase 3 study evaluating tislelizumab in combination with cisplatin and gemcitabine, with or without trilaciclib, for untreated unresectab…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China
A multicenter clinical trial in China is evaluating a urine DNA test for bladder cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CBX-12 in adults with advanced or metastatic refractory solid tumors. The trial includes multiple cancer types and is cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
This clinical trial update notes a study analyzing primary and metastatic tumors in patients with renal cell carcinoma and urothelial carcin…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) [NA]
The LAYOVER trial evaluating locally ablative therapy for oligoprogressive genitourinary tumors is currently recruiting in prostate cancer, …
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: A Phase 2 Clinical Study of ABSK061 and ABSK043 [Phase 2]
Abbisko Therapeutics is recruiting for a Phase 2 study of ABSK061 and ABSK043 in multiple cancers, including HER2-positive gastric/gastroeso…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial of SHR-A2102 in combination with antitumor therapy is being conducted for advanced urothelial carcinoma and is cu…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma
A status update for NCT06663735 indicates the urothelial carcinoma trial sponsored by The First Affiliated Hospital of Xinxiang Medical Coll…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: 9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer [Phase 3]
A Phase 3 clinical trial evaluating 9MW2821 in combination with toripalimab versus standard chemotherapy for locally advanced or metastatic …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: 9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer [Phase 1, Phase 2]
This update covers a Phase 1/2 clinical trial of 9MW2821 in combination with toripalimab for advanced urothelial carcinoma. The study is cur…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease [Phase 2]
Phase 2 clinical trial exploring immunotherapy combined with carbon ion radiotherapy in solid cancers with stable disease, currently recruit…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors [Phase 1]
RemeGen's RC198 is being evaluated in a Phase 1 study across locally advanced unresectable or metastatic solid tumors, including melanoma, u…
-
CLINICAL_TRIALS research · 2024-08-13Clinical Trial Update: Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor [Phase 2]
Phase 2 clinical trial update on pemigatinib plus an immune checkpoint inhibitor for FGFR1/2/3-altered advanced solid tumors; the study is n…
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria
This clinical trial evaluates a urine DNA methylation test for detecting urothelial carcinoma in patients with hematuria.
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Urine DNA Methylation Detection for Hematuria Evaluation
ClinicalTrials.gov entry for a study evaluating urine DNA methylation as a noninvasive test to evaluate hematuria and screen for urothelial …
-
CLINICAL_TRIALS research · 2018-07-31Clinical Trial Update: The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer [NA]
Clinical trial update on the efficacy of neoadjuvant atezolizumab in advanced urothelial carcinoma; current status is unknown.
-
CLINICAL_TRIALS research · 2015-05-12Clinical Trial Update: BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma [Phase 2]
Phase 2 clinical trial update of BIBF1120 (nintedanib) in advanced urothelial carcinoma, including FGFR3-mutant, FGFR3-overexpressed, or wil…
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Gemcitabine-Carboplatin Versus Gemcitabine-Oxaliplatin in Cisplatin-unfit Urothelial Carcinoma [Phase 2]
A Phase 2 clinical trial is comparing gemcitabine-carboplatin to gemcitabine-oxaliplatin in cisplatin-unfit advanced urothelial carcinoma. T…
-
CLINICAL_TRIALS research · 2014-01-28Clinical Trial Update: Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU) [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing cabazitaxel to vinflunine in metastatic or locally advanced urothelial carcinoma, with the study status li…
-
CLINICAL_TRIALS research · 2013-11-25Clinical Trial Update: EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells
This clinical trial update describes an in vitro study examining whether epigallocatechin gallate (EGCG) can modulate the cytotoxic effects …
-
CLINICAL_TRIALS research · 2012-02-22Clinical Trial Update: Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
A clinical trial update examining aristolochic acid–DNA adducts in urothelial carcinoma patients in Taiwan.
-
CLINICAL_TRIALS research · 2011-06-22Clinical Trial Update: DNA Methylation and Urothelial Carcinoma
This clinical trial update from China Medical University Hospital investigates DNA methylation in urothelial carcinoma; the current status o…
-
CLINICAL_TRIALS research · 2011-05-27Clinical Trial Update: DNA Methylation and Arsenic-associated Urothelial Carcinoma
This clinical trial update investigates DNA methylation in arsenic-associated urothelial carcinoma, sponsored by China Medical University Ho…